Suppr超能文献

静脉注射甲泼尼龙和口服泼尼松在多发性硬化症中的生物利用度。

The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis.

作者信息

Morrow S A, Stoian C A, Dmitrovic J, Chan S C, Metz L M

机构信息

Department of Clinical Neurosciences, University of Western Ontario, London, Ontario, Canada.

出版信息

Neurology. 2004 Sep 28;63(6):1079-80. doi: 10.1212/01.wnl.0000138572.82125.f5.

Abstract

Oral prednisone (1)might be a convenient, inexpensive alternative to IV methylprednisolone (IVMP) if the bioequivalent dose was known. We compared the total amount of steroid absorbed after 1250 mg oral prednisone vs 1 gram IVMP in 16 patients with multiple sclerosis (MS). At 24 hours, the mean area under the concentration-time curve (AUC), the main component of bioavailability, did not differ between groups (p = 0.122). This suggests that the amount of absorbed corticosteroid is similar after either steroid at these doses.

摘要

如果已知生物等效剂量,口服泼尼松(1)可能是静脉注射甲泼尼龙(IVMP)方便且便宜的替代药物。我们比较了16例多发性硬化症(MS)患者口服1250 mg泼尼松与静脉注射1 g IVMP后吸收的类固醇总量。在24小时时,浓度-时间曲线下的平均面积(AUC)(生物利用度的主要组成部分)在两组之间没有差异(p = 0.122)。这表明在这些剂量下,两种类固醇后吸收的皮质类固醇量相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验